Ann Wilson, iconic singer of Heart, has bravely disclosed her recent cancer diagnosis and subsequent decision to undergo chemotherapy, prompting the postponement of her remaining 2024 concert dates.
Speaking candidly on X, Wilson, 74, shared that a recent operation revealed cancer, which she assured fans was successfully treated. Despite feeling great post-surgery, her doctors have recommended preventive chemotherapy, prompting Wilson to prioritize her health by stepping away from the stage for the remainder of the year.
The renowned vocalist, known for hits like “Barracuda,” expressed gratitude for the support and understanding of her fans, emphasizing that her team is diligently working to reschedule postponed shows and will update ticket holders accordingly.
Heart, the band co-founded by Wilson and her sister Nancy, had been actively touring as part of their “Royal Flush Tour,” initially slated to continue through mid-December. Wilson assured fans that this hiatus is temporary, affirming her intention to return to performing in 2025, stating emphatically, “This is merely a pause. I’ve much more to sing.”
Wilson’s announcement underscores her resilience and determination to prioritize her well-being while reassuring fans of her eventual return to the stage. Her openness about her health journey serves as an inspiration to many, highlighting the importance of taking necessary steps for recovery and maintaining hope for the future.